bradley mcgregor, md, on mrcc patients whose cancer returns and were previously treated with i-o
Published 4 years ago • 27 plays • Length 1:13
Download video MP4
Download video MP3
Similar videos
-
2:09
bradley mcgregor, md, considers the optimal approach to treating newly diagnosed rcc patients
-
1:18
bradley mcgregor, md, considers strategies for treating 2nd line rcc patients
-
1:16
bradley mcgregor, md, on the data regarding enfortumab in post-platinum i-o bladder cancer
-
1:19
bradley mcgregor, md, on impressions of the oral inhibitor study in renal cell carcinoma patients
-
1:29
bradley mcgregor, md, on combo ipilimumab nivolumab in variant histologies of bladder cancer
-
1:32
bradley mcgregor, md, shares presented data investigating atezolizumab and cabozantinib in mcrpc
-
1:01
bradley mcgregor, md, describes if biomarkers help guide treatment in advanced renal cell carcinoma
-
1:34
dr mcgregor on the clinical implications of the dad-io trial in urothelial carcinoma
-
2:06
dr. mcgregor on whether patients need frontline combinations in rcc
-
1:03
dr. mcgregor on the evolving treatment landscape of rcc
-
1:49
dr. mcgregor on immunotherapy combinations in kidney cancer
-
1:59
are organic foods essential for cancer prevention?
-
0:59
dr. mcgregor on future research in mcrpc
-
1:47
dr. mcgregor on choosing a combination therapy regimen in advanced rcc
-
1:44
dr. mcgregor on treating genitourinary cancer | dana-farber cancer institute
-
0:53
dr. mcgregor on challenges facing frontline treatments for rcc
-
1:18
dr mcgregor on the rationale for the dad trial in metastatic urothelial cancer
-
4:50
hope for brain cancer patients
-
2:38
what is the treatment for brain cancer?
Clip.africa.com - Privacy-policy